SCHEMBL2668271

SCHEMBL2668271

CC(=O)Cc1csc(NC(=O)C(C)(C)Oc2ccc(O)c(O)c2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.47
▸ ALDH1A1 P00352 3/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ HTT P42858 2/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ TYR P14679 2/20 0.44
▸ KCNH2 Q12809 1/20 0.42
▸ MAPT P10636 3/20 0.41
▸ MRE11 P49959 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ PDE5A O76074 1/20 0.39
▸ PDE1A P54750 1/20 0.39
▸ PDE1B Q01064 1/20 0.39
▸ PDE1C Q14123 1/20 0.39
▸ MAPK1 P28482 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2656187 0.79 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1NPC1RAB9ALMNA
SCHEMBL2660279 0.75 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1NPC1RAB9ALMNA
SCHEMBL2658175 0.74 POLB (0.52) SMN1; SMN2ALDH1A1NPC1RAB9ALMNA
SCHEMBL10200000 0.71 ALDH1A1 (0.44) ALDH1A1
SCHEMBL2657189 0.70 MAPT (0.44) SMN1; SMN2ALDH1A1NPC1RAB9ALMNA
SCHEMBL2656339 0.70 SMN1; SMN2 (0.47) SMN1; SMN2ALDH1A1NPC1RAB9ALMNA
SCHEMBL2656819 0.69 PPARA (0.43) SMN1; SMN2ALDH1A1NPC1RAB9ALMNA
SCHEMBL2657487 0.69 GCK (0.67) SMN1; SMN2ALDH1A1NPC1RAB9ALMNA
SCHEMBL2657687 0.67 ALDH1A1 (0.51) SMN1; SMN2ALDH1A1LMNAMAPTTP53
SCHEMBL2658354 0.67 MAPT (0.46) SMN1; SMN2ALDH1A1RAB9ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008104994-A2 2,2,2-TRI-SUBSTITUTED ACETAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2008-09-04 — — WO disclosed
Send feedback